Abstract:Background: Since gamma delta (gamma delta) T cells are involved in various autoimmune diseases, we aimed to verify whether gamma delta T cells participate in the pathogenesis of Sjogren's syndrome (SS) and related pulmonary inflammation, and also aimed to evaluate the effects of umbilical cord mesenchymal stem cells (MSCs) on SS-related pulmonary inflammation and the gamma delta T cells. Methods: The saliva flow rates of female non-obese diabetic (NOD/Ltj) mice were measured. Histopathologic analysis was performed in salivary glands (SG) and lung tissues. The levels of gamma delta T cells and their subsets in the peripheral blood, spleen, and lung were examined by flow cytometry. The purified gamma delta T cells were adoptively transferred into NOD/Ltj mice. MSC transplantation was performed in 8-week-old NOD/Ltj mice. Results: The results showed lymphocytic infiltration in SG and lacrimal glands (LG), and reduction of saliva flow rates in 8-week NOD/Ltj mice. The levels of gamma delta T cells decreased in peripheral blood, but increased in the lung and spleen of 8- and 12-week-old NOD/Ltj mice. The proportions and numbers of V gamma 4+ T cells and V gamma 4+ IL-17A+ T cells increased in the lung, but decreased in peripheral blood of 8-week-old NOD/Ltj mice. Notably, transfer of gamma delta T cells decreased the rate of saliva flow, as well as aggravated the pathological changes in the SG and lung. The transplantation of MSCs increased saliva flow rate and alleviated pathological injury in the SG and lung. The frequencies of V gamma 4+ T cells and V gamma 4+ IL-17A+ T cells in the lung and spleen significantly decreased after MSC treatment. Our results demonstrated that gamma delta T cells and their subsets contribute to the pathogenesis of SS and SS-related pulmonary inflammation. In addition, MSCs relieved SS and SS-related pulmonary inflammation through suppressing V gamma 4+ IL-17A+ T cells. Conclusions: Peripheral V gamma 4+ T cells infiltrate into the lung in SS mice, and aggravate the symptoms of SS and SS-related pulmonary inflammation by secreting IL-17A. Meanwhile, lymphocyte infiltration could be reversed by MSC transplantation, which indicates the potential of MSCs in the treatment of SS and SS-related pulmonary inflammation patients

Mesenchymal Stem Cells Combined with Traditional Chinese Medicine (Qi-Fang-bi-min-tang) Alleviates Rodent Allergic Rhinitis.

Mesenchymal Stromal Cells Ameliorate Acute Allergic Rhinitis in Rats

Bone Marrow-Derived Mesenchymal Stem Cells Reduce Immune Reaction in a Mouse Model of Allergic Rhinitis.

Nasal Mucosa Derived-Mesenchymal Stem Cells from Mice Reduce Inflammation via Modulating Immune Responses

Effect and mechanism of human umbilical cord mesenchymal stem cells in treating allergic rhinitis in mice

Adipose Tissue-Derived Mesenchymal Stem Cell Modulates the Immune Response of Allergic Rhinitis in a Rat Model

Effect of mesenchymal stem cell therapy in animal models of allergic rhinitis: A systematic review and meta -analysis

Intranasal Delivery of Mesenchymal Stem Cell Exosomes Modulates the Immune Response of Allergic Rhinitis Via the MAPK Pathway in a Mouse Model

Therapeutic Effects of Human Pluripotent Stem Cell-Derived Mesenchymal Stem Cells on a Murine Model of Acute Type-2-Dominated Airway Inflammation

The function and mechanism of Human nasal mucosa-derived mesenchymal stem cells in allergic rhinitis in mice

Gingival-derived Mesenchymal Stem Cells Alleviate Allergic Asthma Inflammation Via HGF in Animal Models

Mesenchymal Stem Cells Prevent Overwhelming Inflammation and Reduce Infection Severity Via Recruiting CXCR3+ Regulatory T Cells

Research progress in therapeutic action of mesenchymal stem cell in allergic rhinitis

Immunomodulatory properties of mesenchymal stem cells: a potential therapeutic strategy for allergic rhinitis

Comparable Therapeutic Potential of Umbilical Cord Mesenchymal Stem Cells in Collagen-Induced Arthritis to TNF Inhibitor or Anti-Cd20 Treatment.

Umbilical Cord Mesenchymal Stem Cells Alleviate Sjögren's Syndrome and Related Pulmonary Inflammation Through Regulating Vγ4+ IL-17+ T Cells.

Mesenchymal Stem Cells Derived from Human Induced Pluripotent Stem Cells Modulate T-cell Phenotypes in Allergic Rhinitis

The Effect of Mesenchymal Stem Cells on Dynamic Changes of T Cell Subsets in Experimental Autoimmune Uveoretinitis

Human Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Prevent Allergic Airway Inflammation in Mice

New insights into allergic rhinitis treatment: MSC nanovesicles targeting dendritic cells

Culture medium from TNF-α-stimulated mesenchymal stem cells attenuates allergic conjunctivitis through multiple antiallergic mechanisms